Keratinocytes: An Enigmatic Factor in Atopic Dermatitis.

Area of Science:

• Dermatology
• Immunology
• Cell Biology

Background:

• Atopic dermatitis (AD) is a prevalent chronic inflammatory skin disease affecting 1-20% globally, often starting in childhood and linked to other atopic conditions.
• Pathogenesis involves epidermal barrier dysfunction, abnormal cytokine expression, and immune cell infiltration.
• Current diagnostic biomarkers and curative treatments for AD are limited, necessitating further research.

Purpose of the Study:

• To review the multifaceted role of epidermal keratinocytes in the pathogenesis of atopic dermatitis.
• To explore how keratinocyte dysfunction contributes to the inflammatory processes in AD.
• To identify potential therapeutic targets related to keratinocytes for novel AD treatments.

Main Methods:

• Literature review focusing on immunological aspects and epidermal barrier function in AD.
• Analysis of studies investigating keratinocyte responses to various triggers (allergens, irritants, microbes).
• Examination of genetic and molecular factors influencing keratinocyte behavior in AD.

Main Results:

• Keratinocytes are key initiators of the inflammatory response in AD, releasing pro-inflammatory mediators, cytokines, and chemokines.
• Disrupted epidermal barriers, genetic factors (SNPs), and environmental triggers directly impact keratinocyte function.
• Aberrant keratinocyte signaling contributes significantly to AD pathophysiology.

Conclusions:

• Keratinocytes play a crucial and widespread role in the development and exacerbation of atopic dermatitis.
• Understanding keratinocyte involvement opens new avenues for targeted AD therapies.
• Further research into keratinocyte-centric treatments is warranted for effective AD management.